Harry Dolstra received his Master’s degree from the University of Utrecht in 1993 in Molecular-Cellular Biology. He then received his doctorate (cum laude) from the University of Nijmegen in 1999 under supervision of Prof. T. de Witte and Prof. C. Figdor. The topic of his thesis was "Donor cytotoxic T cell responses against leukemia in allogeneic bone marrow recipients“. He completed his post-doctorate work at the Radboud University Medical Center and the CRC for Cancer studies in Birmingham, UK.
From 2009 he became Principal Investigator in the field of "Cancer Immunotherapy", which is centered on the characterization and modulation of immune reactions involved in the antitumor response against hematological malignancies. His program comprises five intermingled research lines: 1) development of novel strategies to boost antitumor immunity after allogeneic stem cell transplantation, 2) co-signaling pathways involved in tumor immune escape, 3) migratory pathways directing T- and NK-cell homing to tumor sites, 4) DC-based vaccination strategies against hematological cancers, and 5) NK cell-based immunotherapy against leukemia, multiple myeloma and ovarian cancer.
Harry Dolstra is Associate Professor in Translational ImmunoHematology at the Laboratory of Hematology – Department of Laboratory Medicine. In addition, he has a role in supervision of Stem and Immune cell processing and Immunophenotyping for patient care.
National & International Personal Prizes & Awards
- George Santos award for best clinical article in 2014 for which I was senior author, American Society for Blood and Marrow Transplantation, 2014.
- ZonMw project award Translational Adult Stem cell program handed by the State Secretary Bussemaker of the Ministry of Health on 26th October 2009.
- Leukemia Research grant from the "Bekales" foundation 11-5-2004.
- Leukemia Research award from the "Bekales" foundation 22-5-2000.
- Stipendium "Ank van Vlissingen Foundation" 29-3-2000.
- Herman Boerhaave award in the field of Hematology 18-2-2000.
<< go back